Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy
Authors
Keywords
-
Journal
Cellular & Molecular Immunology
Volume 18, Issue 9, Pages 2083-2100
Publisher
Springer Science and Business Media LLC
Online
2021-07-16
DOI
10.1038/s41423-021-00732-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Generating natural killer cells for adoptive transfer: expanding horizons
- (2021) Soumyadipta Kundu et al. CYTOTHERAPY
- A robust platform for expansion and genome editing of primary human natural killer cells
- (2021) Rih-Sheng Huang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Translating Unconventional T Cells and Their Roles in Leukemia Antitumor Immunity
- (2021) Nilberto Dias de Araújo et al. Journal of Immunology Research
- Engineering NK Cells for CAR Therapy—Recent Advances in Gene Transfer Methodology
- (2021) Paula Schmidt et al. Frontiers in Immunology
- Arrested development: suppression of NK cell function in the tumor microenvironment
- (2021) Luke Riggan et al. Clinical & Translational Immunology
- CD19 CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different CD19-directed CAR T-cell therapies
- (2021) Yun Liang et al. Journal of Hematology & Oncology
- Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model
- (2021) Yanan Wang et al. Frontiers in Immunology
- The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting
- (2021) Yang Li et al. Frontiers in Immunology
- Bispecific c-Met/PD-L1 CAR-T Cells Have Enhanced Therapeutic Effects on Hepatocellular Carcinoma
- (2021) Wei Jiang et al. Frontiers in Oncology
- Targeting Innate Immunity in Cancer Therapy
- (2021) Srikrishnan Rameshbabu et al. Vaccines
- The tumor microenvironment shapes the molecular characteristics of exhausted CD8+ T cells
- (2021) Hongcheng Cheng et al. CANCER LETTERS
- Enhancing CAR-T cell efficacy in solid tumors by targeting the tumor microenvironment
- (2021) Guangna Liu et al. Cellular & Molecular Immunology
- Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
- (2021) Ying Gong et al. Journal of Hematology & Oncology
- Use of chimeric antigen receptor NK-92 cells to target mesothelin in ovarian cancer
- (2020) Bihui Cao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A novel bispecific chimeric PD1-DAP10/NKG2D receptor augments NK92-cell therapy efficacy for human gastric cancer SGC-7901 cell
- (2020) Mingfeng Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma
- (2020) Guangna Liu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Prospects and Challenges for Use of CAR T Cell Therapies in Solid Tumors
- (2020) Sneha Ramakrishna et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- TEG011 persistence averts extramedullary tumor growth without exerting off‐target toxicity against healthy tissues in a humanized HLA‐A*24:02 transgenic mice
- (2020) Inez Johanna et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The therapeutic landscape for cells engineered with chimeric antigen receptors
- (2020) Matthew MacKay et al. NATURE BIOTECHNOLOGY
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells
- (2020) Marc Rigau et al. SCIENCE
- High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia
- (2020) Stephan Müller et al. Frontiers in Immunology
- Targeting Natural Killer Cells for Tumor Immunotherapy
- (2020) Cai Zhang et al. Frontiers in Immunology
- Emerging Approaches for Regulation and Control of CAR T Cells: A Mini Review
- (2020) Lærke J. B. Brandt et al. Frontiers in Immunology
- The Emerging Landscape of Immune Cell Therapies
- (2020) Evan W. Weber et al. CELL
- Engineering bionic T cells: signal 1, signal 2, signal 3, reprogramming and the removal of inhibitory mechanisms
- (2020) Iñaki Etxeberria et al. Cellular & Molecular Immunology
- Signaling from T cell receptors (TCRs) and chimeric antigen receptors (CARs) on T cells
- (2020) Ling Wu et al. Cellular & Molecular Immunology
- Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing
- (2020) Mohindar M. Karunakaran et al. IMMUNITY
- Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
- (2020) Hanren Dai et al. Journal of Hematology & Oncology
- Enhanced NK-92 Cytotoxicity by CRISPR Genome Engineering Using Cas9 Ribonucleoproteins
- (2020) Rih-Sheng Huang et al. Frontiers in Immunology
- DNAM1 and 2B4 Costimulatory Domains Enhance the Cytotoxicity of Anti-GPC3 Chimeric Antigen Receptor-Modified Natural Killer Cells Against Hepatocellular Cancer Cells in vitro
- (2020) Yao Huang et al. Cancer Management and Research
- Phase II study of α-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer
- (2020) Takahide Toyoda et al. Journal for ImmunoTherapy of Cancer
- PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations
- (2020) Kellsye P Fabian et al. Journal for ImmunoTherapy of Cancer
- Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches
- (2020) Stefania Mantovani et al. Cancers
- Adaptor CAR Platforms—Next Generation of T Cell-Based Cancer Immunotherapy
- (2020) Claudia Arndt et al. Cancers
- The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy
- (2020) Yuxia Liu et al. Cells
- γδ T Cells: The Ideal Tool for Cancer Immunotherapy
- (2020) Mahboubeh Yazdanifar et al. Cells
- CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomas
- (2020) Margery Gang et al. BLOOD
- Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity
- (2020) Huang Zhu et al. Cell Stem Cell
- Cancer immunotherapy with γδ T cells: many paths ahead of us
- (2020) Dieter Kabelitz et al. Cellular & Molecular Immunology
- Ligand recognition by the γδ TCR and discrimination between homeostasis and stress conditions
- (2020) Malte Deseke et al. Cellular & Molecular Immunology
- Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment
- (2020) Xingyi Pan et al. Cellular & Molecular Immunology
- The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
- (2020) Yuanyuan Zhang et al. Cellular & Molecular Immunology
- Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumors
- (2020) Emmanuel Donnadieu et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A novel chimeric PD1-NKG2D-41BB receptor enhances antitumor activity of NK92 cells against human lung cancer H1299 cells by triggering pyroptosis
- (2020) Chengui Lu et al. MOLECULAR IMMUNOLOGY
- Rewriting History: Epigenetic Reprogramming of CD8+ T Cell Differentiation to Enhance Immunotherapy
- (2020) Caitlin C. Zebley et al. TRENDS IN IMMUNOLOGY
- Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
- (2020) Keerthana Shankar et al. Stem Cell Research & Therapy
- Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation
- (2020) Lixia Sheng et al. Frontiers in Immunology
- Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
- (2020) Meir Rozenbaum et al. Frontiers in Immunology
- Electroporation of NKG2D RNA CAR Improves Vγ9Vδ2 T Cell Responses against Human Solid Tumor Xenografts
- (2020) Wei Xia Ang et al. Molecular Therapy-Oncolytics
- IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment
- (2020) Mélanie Desbois et al. Journal for ImmunoTherapy of Cancer
- Anti-PSMA CAR-Engineered NK-92 Cells: An Off-the-Shelf Cell Therapy for Prostate Cancer
- (2020) Isabella Monia Montagner et al. Cells
- Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells
- (2020) May Daher et al. BLOOD
- Human immunology and immunotherapy: main achievements and challenges
- (2020) Jezabel Varadé et al. Cellular & Molecular Immunology
- Clinical development of CAR T cell therapy in China: 2020 update
- (2020) Jianshu Wei et al. Cellular & Molecular Immunology
- Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer
- (2020) Yongyan Chen et al. Cellular & Molecular Immunology
- CD19-Specific CAR-T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor is Effective in Patients with PD-L1 Positive B-Cell Lymphoma
- (2020) Hui Liu et al. CLINICAL CANCER RESEARCH
- Overcoming key challenges in cancer immunotherapy with engineered T cells
- (2020) Silvia Arcangeli et al. CURRENT OPINION IN ONCOLOGY
- BCMA-targeted immunotherapy for multiple myeloma
- (2020) Bo Yu et al. Journal of Hematology & Oncology
- Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis
- (2020) Andras Heczey et al. NATURE MEDICINE
- Exploring the NK cell platform for cancer immunotherapy
- (2020) Jacob A. Myers et al. Nature Reviews Clinical Oncology
- Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies
- (2020) Elizabeth L. Siegler et al. Frontiers in Immunology
- Highly Efficient Generation of Transgenically Augmented CAR NK Cells Overexpressing CXCR4
- (2020) Arezoo Jamali et al. Frontiers in Immunology
- Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study
- (2020) Kazuhiro Kakimi et al. Journal for ImmunoTherapy of Cancer
- Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells
- (2020) Benjamin Ruf et al. Cellular & Molecular Immunology
- Chimeric antigen receptor T cells immunotherapy: challenges and opportunities in hematological malignancies
- (2020) Nashwa El-Khazragy et al. Immunotherapy
- Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
- (2020) Ahmet Yilmaz et al. Journal of Hematology & Oncology
- Innate and Innate-Like Cells: The Future of Chimeric Antigen Receptor (CAR) Cell Therapy
- (2020) Diana Cortés-Selva et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Tumor-Infiltrating Natural Killer Cells
- (2020) Beatriz Cózar et al. Cancer Discovery
- Outlook for New CAR-Based Therapies with a Focus on CAR NK Cells: What Lies Beyond CAR-Engineered T Cells in the Race against Cancer
- (2020) May Daher et al. Cancer Discovery
- Innate lymphoid cells: from helper to killer
- (2020) Lisette Krabbendam et al. CURRENT OPINION IN IMMUNOLOGY
- NK cells expressing a chimeric activating receptor eliminate MDSCs and rescue impaired CAR-T cell activity against solid tumors
- (2019) Robin Parihar et al. Cancer Immunology Research
- Evaluating in vivo efficacy – toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells
- (2019) Inez Johanna et al. Journal for ImmunoTherapy of Cancer
- Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma
- (2019) Mohammed Alnaggar et al. Journal for ImmunoTherapy of Cancer
- Broad Cytotoxic Targeting of Acute Myeloid Leukemia by Polyclonal Delta One T Cells
- (2019) Biagio Di Lorenzo et al. Cancer Immunology Research
- Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients
- (2019) Lin Xiao et al. MOLECULAR THERAPY
- A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation
- (2019) Yunyun Yang et al. IMMUNITY
- Optimizing intracellular signaling domains for CAR NK cells in HIV immunotherapy: a comprehensive review
- (2019) Giorgio Zenere et al. DRUG DISCOVERY TODAY
- Targeting natural killer cells in solid tumors
- (2019) Guillaume Habif et al. Cellular & Molecular Immunology
- NK cell recognition of hematopoietic cells by SLAM-SAP families
- (2019) Shasha Chen et al. Cellular & Molecular Immunology
- Human NK cells: surface receptors, inhibitory checkpoints, and translational applications
- (2019) Simona Sivori et al. Cellular & Molecular Immunology
- Innate lymphocytes—lineage, localization and timing of differentiation
- (2019) Emily R. Kansler et al. Cellular & Molecular Immunology
- Innate lymphoid cell memory
- (2019) Xianwei Wang et al. Cellular & Molecular Immunology
- Engineering the TGFβ receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma
- (2019) Rachel A Burga et al. CLINICAL CANCER RESEARCH
- Results of a phase I study of bispecific anti-CD19, anti-CD20 chimeric antigen receptor (CAR) modified T cells for relapsed, refractory, non-Hodgkin lymphoma.
- (2019) Nirav Niranjan Shah et al. JOURNAL OF CLINICAL ONCOLOGY
- 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies
- (2019) Yingxi Xu et al. Journal of Hematology & Oncology
- Multiscale engineering of immune cells and lymphoid organs
- (2019) Sungwoong Kim et al. Nature Reviews Materials
- CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies
- (2019) Lynsey M. Whilding et al. Cancers
- Genetic Reprogramming For NK cell Cancer Immunotherapy with CRISPR /Cas9
- (2019) Lukman O. Afolabi et al. IMMUNOLOGY
- Target selection for CAR-T therapy
- (2019) Jianshu Wei et al. Journal of Hematology & Oncology
- CAR-T Engineering: Optimizing Signal Transduction and Effector Mechanisms
- (2019) Emiliano Roselli et al. BIODRUGS
- NKT cells co-expressing a GD2-specific chimeric antigen receptor and IL-15 show enhanced in vivo persistence and antitumor activity against neuroblastoma
- (2019) Xin Xu et al. CLINICAL CANCER RESEARCH
- Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies
- (2019) Zsolt Sebestyen et al. NATURE REVIEWS DRUG DISCOVERY
- A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function
- (2019) Shiran Hoogi et al. Journal for ImmunoTherapy of Cancer
- Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor
- (2019) Sourav Paul et al. Journal for ImmunoTherapy of Cancer
- CAR-NK for tumor immunotherapy: Clinical transformation and future prospects
- (2019) Wenxiu Wang et al. CANCER LETTERS
- Engineered Stem Cells Provide Cancer-Killing iNKT Cells
- (2019) Mallory Paynich Murray et al. Cell Stem Cell
- Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer
- (2019) Yanni Zhu et al. Cell Stem Cell
- Myeloid immunosuppression and immune checkpoints in the tumor microenvironment
- (2019) Kyohei Nakamura et al. Cellular & Molecular Immunology
- Immunological memory: ILC1s come into view
- (2019) Yawen Chen et al. Cellular & Molecular Immunology
- Chimeric antigen receptor T cell therapies for multiple myeloma
- (2019) Chao Wu et al. Journal of Hematology & Oncology
- A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy
- (2019) Emily J. Pomeroy et al. MOLECULAR THERAPY
- CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
- (2019) Michael C. Burger et al. Frontiers in Immunology
- Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment
- (2019) Yangjing Zhao et al. Cellular & Molecular Immunology
- Targeting T cell malignancies using CAR-based immunotherapy: challenges and potential solutions
- (2019) Lauren C. Fleischer et al. Journal of Hematology & Oncology
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- CXCR1 Expression to Improve Anti-Cancer Efficacy of Intravenously Injected CAR-NK Cells in Mice with Peritoneal Xenografts
- (2019) Yu Yang Ng et al. Molecular Therapy-Oncolytics
- Synthetic Biology: Immunotherapy by Design
- (2018) Matthew J. Brenner et al. Annual Review of Biomedical Engineering
- First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
- (2018) Rizwan Romee et al. BLOOD
- Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
- (2018) Ye Li et al. Cell Stem Cell
- Activated pancreatic stellate cells inhibit NK cell function in the human pancreatic cancer microenvironment
- (2018) Qiang Huang et al. Cellular & Molecular Immunology
- Driving CARs on the uneven road of antigen heterogeneity in solid tumors
- (2018) Nan Chen et al. CURRENT OPINION IN IMMUNOLOGY
- Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models
- (2018) Bai Liu et al. CYTOKINE
- Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma
- (2018) Haneen Shalabi et al. HAEMATOLOGICA
- hIL-15-gene modified human natural killer cells (NKL-IL15) exhibit anti-human leukemia functions
- (2018) Wen Jiang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation
- (2018) Anna Capsomidis et al. MOLECULAR THERAPY
- Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication
- (2018) Christopher C. Kloss et al. MOLECULAR THERAPY
- Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
- (2018) Qing Zhang et al. NATURE IMMUNOLOGY
- Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma
- (2018) Haneen Shalabi et al. HAEMATOLOGICA
- Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37
- (2018) Dhifaf Sarhan et al. Cancer Immunology Research
- Working in “NK Mode”: Natural Killer Group 2 Member D and Natural Cytotoxicity Receptors in Stress-Surveillance by γδ T Cells
- (2018) Bruno Silva-Santos et al. Frontiers in Immunology
- GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR
- (2018) Trudy Straetemans et al. Frontiers in Immunology
- Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model
- (2018) Maaike V. J. Braham et al. OncoImmunology
- Innate Lymphoid Cells: 10 Years On
- (2018) Eric Vivier et al. CELL
- Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
- (2018) Sarwish Rafiq et al. NATURE BIOTECHNOLOGY
- Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy
- (2018) Kris M. Mahadeo et al. Nature Reviews Clinical Oncology
- Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting
- (2018) Antonia Rotolo et al. CANCER CELL
- Transmembrane domain-mediated Lck association underlies bystander and costimulatory ICOS signaling
- (2018) Zurong Wan et al. Cellular & Molecular Immunology
- Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells
- (2018) Michelle L. Saetersmoen et al. Seminars in Immunopathology
- Engineered T Cell Therapies from a Drug Development Viewpoint
- (2018) Fang Chen et al. Engineering
- Natural Killer Cell-Based Immunotherapy for Cancer: Advances and Prospects
- (2018) Yuan Hu et al. Engineering
- Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
- (2017) Paul A. Beavis et al. JOURNAL OF CLINICAL INVESTIGATION
- Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor
- (2017) Jonathan Fisher et al. MOLECULAR THERAPY
- Engineering Natural Killer Cells for Cancer Immunotherapy
- (2017) Katayoun Rezvani et al. MOLECULAR THERAPY
- Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer
- (2017) Somala Mohammed et al. MOLECULAR THERAPY
- Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
- (2017) Melissa Bedard et al. Frontiers in Immunology
- Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential
- (2017) Christian W. Keller et al. Frontiers in Immunology
- Natural Killer T Cells in Cancer Immunotherapy
- (2017) Shiny Nair et al. Frontiers in Immunology
- Natural Killer Cell Memory: Progress and Implications
- (2017) Hui Peng et al. Frontiers in Immunology
- Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
- (2017) Veronika Kremer et al. Journal for ImmunoTherapy of Cancer
- A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors
- (2016) Xiaojun Liu et al. CANCER RESEARCH
- Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells
- (2016) Dhifaf Sarhan et al. CANCER RESEARCH
- Delta One T Cells for Immunotherapy of Chronic Lymphocytic Leukemia: Clinical-Grade Expansion/Differentiation and Preclinical Proof of Concept
- (2016) A. R. Almeida et al. CLINICAL CANCER RESEARCH
- Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
- (2016) Leonid Cherkassky et al. JOURNAL OF CLINICAL INVESTIGATION
- CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo
- (2016) Gengwen Tian et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-15Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists
- (2016) Mélanie Desbois et al. JOURNAL OF IMMUNOLOGY
- In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma
- (2016) Joseph G. Pressey et al. MEDICINE
- CIS is a potent checkpoint in NK cell–mediated tumor immunity
- (2016) Rebecca B Delconte et al. NATURE IMMUNOLOGY
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
- (2016) Rizwan Romee et al. Science Translational Medicine
- Efficient Regeneration of Human Vα24+Invariant Natural Killer T Cells and Their Anti-Tumor Activity In Vivo
- (2016) Daisuke Yamada et al. STEM CELLS
- Toxicity and management in CAR T-cell therapy
- (2016) Challice L Bonifant et al. Molecular Therapy-Oncolytics
- Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs
- (2015) Soranobu Ninomiya et al. BLOOD
- Untouched GMP-Ready Purified Engineered Immune Cells to Treat Cancer
- (2015) T. Straetemans et al. CLINICAL CANCER RESEARCH
- Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional
- (2015) Wenji Sun et al. CYTOKINE
- DAP12-Based Activating Chimeric Antigen Receptor for NK Cell Tumor Immunotherapy
- (2015) Katrin Töpfer et al. JOURNAL OF IMMUNOLOGY
- Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
- (2015) Nadja Müller et al. JOURNAL OF IMMUNOTHERAPY
- Genetic engineering of hematopoietic stem cells to generate invariant natural killer T cells
- (2015) Drake J. Smith et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- γδT Cells: First Line of Defense and Beyond
- (2014) Yueh-hsiu Chien et al. Annual Review of Immunology
- Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15
- (2014) M. Imamura et al. BLOOD
- Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy
- (2014) A. Heczey et al. BLOOD
- hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo
- (2014) Wen Jiang et al. IMMUNOBIOLOGY
- Cytotoxic and Regulatory Properties of Circulating Vδ1+ γδ T Cells: A New Player on the Cell Therapy Field?
- (2014) Gabrielle M Siegers et al. MOLECULAR THERAPY
- IL-15.IL-15R complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells
- (2014) F. Tamzalit et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Platform for Induction and Maintenance of Transgene-free hiPSCs Resembling Ground State Pluripotent Stem Cells
- (2014) Bahram Valamehr et al. Stem Cell Reports
- Are natural killer cells superior CAR drivers?
- (2014) Hans Klingemann OncoImmunology
- A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor Cells
- (2013) Y.-H. Chang et al. CANCER RESEARCH
- Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy
- (2013) Bo Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor
- (2013) Drew C Deniger et al. MOLECULAR THERAPY
- CD1d-lipid antigen recognition by the γδ TCR
- (2013) Adam P Uldrich et al. NATURE IMMUNOLOGY
- Natural Cytotoxicity Receptors: Broader Expression Patterns and Functions in Innate and Adaptive Immune Cells
- (2013) Kelly Hudspeth et al. Frontiers in Immunology
- The Adaptor SAP Controls NK Cell Activation by Regulating the Enzymes Vav-1 and SHIP-1 and by Enhancing Conjugates with Target Cells
- (2012) Zhongjun Dong et al. IMMUNITY
- Human T Lymphocytes Are Licensed for Professional Antigen Presentation by Interaction with Opsonized Target Cells
- (2012) N. Himoudi et al. JOURNAL OF IMMUNOLOGY
- Redirecting T cells against cancer cells by transfer of a broadly tumor-reactive T-cell receptor
- (2011) V. Marcu-Malina et al. BLOOD
- Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
- (2011) A J Nicol et al. BRITISH JOURNAL OF CANCER
- Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
- (2011) Hirohito Kobayashi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
- (2011) Joshua M. Lang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adoptive Immunotherapy for Advanced Non-small CellLung Cancer Using Zoledronate-expanded γδTCells
- (2011) Miki Sakamoto et al. JOURNAL OF IMMUNOTHERAPY
- Crystal structure of a T-cell receptor specific for the human MHC class I homolog MICA
- (2011) B. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects
- (2010) J. A. Olson et al. BLOOD
- Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy
- (2010) Kazuki Yamasaki et al. CLINICAL IMMUNOLOGY
- Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A
- (2010) Carmela De Santo et al. NATURE IMMUNOLOGY
- Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
- (2009) Liping Song et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunosuppressive Myeloid-Derived Suppressor Cells Can Be Converted into Immunogenic APCs with the Help of Activated NKT Cells: An Alternative Cell-Based Antitumor Vaccine
- (2009) H.-J. Ko et al. JOURNAL OF IMMUNOLOGY
- Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
- (2008) Jaafar Bennouna et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now